The dementia models induced by intracerebroventricular infusion of β-Amyloid peptide in mice

Chinese Pharmacological Bulletin

Volumn 20, Issue 7, 2004, Pages 827-829

  Chu, Jin ^a   Li, Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Animal model; Beta amyloid peptide; Intracerebroventricular

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN BAX; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEMENTIA; DRUG INDUCED DISEASE; HISTOPATHOLOGY; LEARNING; MEASUREMENT; MEMORY; MOUSE; NONHUMAN; PROTEIN CONTENT; SIMULATION;

EID: 5044236466     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nitta A, Itoh A, Hasegawa T, Nabeshima T. Beta-amyloid protein induced Alzheimer's disease animal model[J]. Neurosci Lett, 1994, 170(1):63-6.
2. Nag S, Yee BK, Tang F. Chronic Intracerebroventricular infusion of beta-amyloid (1-40) results in a selective loss of neuropeptides in addition to a reduction in choline acetyltransferase activity in the cortical mantle and hippocampus in the rat[J]. Ann N Y Acad Sci, 1999, 897(1):420-2.
3. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction[J]. Brain Res, 1996, 706(2):181-93.
4. Itoh A, Akaike T, Sokabe M et al. Impairments of long-term potentiation in hipocampal slices of β-amyloid-infused rats[J]. Eur J Pharmacol, 1999, 382(3):167-75.
5. Nakamara S, Murayama N, Noshita T et al. Progressive brain dysfunction following intracerebroventricular infusion of beta 1-42 amyloid peptide[J]. Brain Res, 2001, 912(2):128-36.
6. Wang R, Zhang HY, Tang XC. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1-40) in rat[J]. Eur J Pharmacol, 2001, 421(3):149-56.
7. Yamaguchi Y, Kawashima S. Effect of amyloid-β-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltranferase activity in the rat[J]. Eur J Pharmacol, 2001, 412:(3) 265-72.
8. Pavia J, Alberch J, Alvarez I et al. Repeated intracerebroventricular administration of β-amyloid 25-35 to rats decreases muscarinic receptors in cerebral cortex[J]. Neurosci Lett, 2000, 278(1-2):69-72.
9. 25-35 region to aggregation and neurotoxicity[J]. J Neurochem, 1995, 64(1):253-65.
10. Neve RL. Mixed signals in Alzheimers disease[J]. Trends-Neurosci, 1996, 19(9):371-2.
11. Yan JJ, Cho Y, Kim HS et al. Protection against β-amyloid peptide toxicity in vivo with long-term admistristration of ferulic acid[J]. Br J Pharmacol, 2001, 133(1):89-96.
12. Gao GQ, Yao ZB, Ma JQ et al. Gene impression of neuronal intric oxide synthase in the brain of senile memory dificit rats[J]. Chin J Geriatr, 1999, 18(4):236-9.
13. Frautschy SA, Yang F, Calderon L et al. Rodent models of Alzheimers disease: Rat A beta infusion approaches to amyloid deposits[J]. Neurobiol Aging, 1996, 17(2):311-21.